MARKET

AUPH

AUPH

Aurinia Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.38
-0.03
-0.47%
Closed 17:32 09/17 EDT
OPEN
6.55
PREV CLOSE
6.41
HIGH
6.55
LOW
6.32
VOLUME
316.31K
TURNOVER
--
52 WEEK HIGH
7.85
52 WEEK LOW
5.06
MARKET CAP
585.87M
P/E (TTM)
-9.1535
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AUPH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AUPH News

  • 22 Healthcare Stocks Moving In Monday's Pre-Market Session
  • Benzinga.1d ago
  • Aurinia Pharma inks $40M stock sales deal with Jefferies
  • seekingalpha.3d ago
  • Aurinia Establishes At-the-Market Facility
  • Business Wire.4d ago
  • Aurinia Pharmaceuticals (AUPH) Investor Presentation - Slideshow
  • Seeking Alpha - Article.6d ago

More

Industry

Biotechnology & Medical Research
+0.24%
Pharmaceuticals & Medical Research
+0.57%

Hot Stocks

Name
Price
%Change

About AUPH

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead compound voclosporin, a therapeutic immunomodulating drug candidate, which is a second-generation calcineurin inhibitors (CNI) to treat patients afflicted with LN. Voclosporin is an oral drug, administered twice daily. It is structurally similar to cyclosporine A (CsA), but is chemically modified on the amino acid-1 residue. It has completed two Phase III clinical studies in patients with moderate to severe psoriasis. It has completed Phase IIb clinical trial, which is a randomized, controlled, double-blind study comparing the efficacy of voclosporin as a component of multi-targeted therapy against placebo in achieving remission in patients with active LN.
More

Webull offers Aurinia Pharmaceuticals Inc (AUPH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.